ARTICLE | Company News
FDA broadens approval for Exact's Cologuard
September 27, 2019 11:07 PM UTC
FDA approved colorectal cancer screening test Cologuard from Exact Sciences Corp. (NASDAQ:EXAS) for average-risk adults ages 45 and older. The non-invasive home-based stool test was marketed for aver...
BCIQ Company Profiles